BioAge Labs (BIOA) Accounts Payables (2023 - 2026)
BioAge Labs (BIOA) posted Accounts Payables of $3.1 million for Q1 2026, up 14.66% sequentially from $2.7 million in Q4 2025, and down 23.14% YoY from $4.0 million in Q1 2025.
BioAge Labs (BIOA) Accounts Payables (2023 - 2026) Analysis & Trends
BioAge Labs has reported Accounts Payables for 4 years, with the latest figure at $3.1 million in Q1 2026.
- Quarterly Accounts Payables fell 23.14% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (down 23.14% YoY) and the FY2025 annual result came in at $2.7 million, up 33.97% from the prior year.
- Accounts Payables grew to $3.1 million in Q1 2026 per BIOA's latest filing, from $2.7 million in the prior quarter.
- Over five years, Accounts Payables peaked at $5.0 million in Q3 2025 and troughed at $1.3 million in Q2 2025.
- A 4-year average of $2.8 million and a median of $2.4 million in 2024 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2025 and 2026: Accounts Payables soared 139.18% in 2025, then declined 23.14% in 2026.
- Over 4 years, Accounts Payables stood at $1.9 million in 2023, then grew by 6.97% to $2.0 million in 2024, then surged by 33.97% to $2.7 million in 2025, then gained by 14.66% to $3.1 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $3.1 million, $2.7 million, and $5.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 356.00 Mn |
| 10 | BioAge Labs | 436.28 Mn | 436.28 Mn | -14.23 Mn | 5.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.65 Mn |
| Mar 31, 2026 | 3.07 Mn |
| Dec 31, 2025 | 2.67 Mn |
| Sep 30, 2025 | 5.02 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | 3.99 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Dec 31, 2023 | 1.87 Mn |